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Cobalt(ous) ion regulates cellular heme metabolism in the intact animal (1-7) 
as welt as in cultured hepatocytes  1 through  effects on the activities of micro- 
somal  heme  oxygenase and  on  the  mitochondrial  enzyme  8-aminolevulinate 
synthetase (ALAS)Y The metal effects on the latter enzyme result in an initial 
inhibition  of ALAS activity which is then followed by induction of the enzyme 
(2,  5).  The  effect  of cobalt  on  heme  oxygenase,  the  enzyme  that  catalyzes 
degradation of heme compounds, is only that of induction (1-7 and footnote 2). 
In the course of a number of studies we have noted that concomitant with the 
induction  of hepatic heme oxygenase by cobalt there is a  marked decrease in 
microsomal heme and cytochrome P-450 contents and prototypic P-450-depend- 
ent  drug-metabolizing  enzyme  activities.  These  observations  have  led  us  to 
propose that  the  increased  activity of heme  oxygenase is responsible for the 
decrease  in  the  cellular  content  of cytochrome  P-450  and  consequently  the 
decrease  in  drug  oxidative  activities  (3,  6,  8).  Studies  with  the  isotopically 
labeled heme precursor 8-aminolevulinate (ALA) have confirmed this idea, and 
supportive evidence for our proposal has also been recently presented by Guze- 
lian and Bissell (9). 
The tumorigenic agents, polychlorinated biphenyls (PCB) cause an induction 
of hepatic ALAS (10) and are potent porphyrinogenic compounds (11); as Alvares 
et  al.  have  shown  they  also  simultaneously  cause  the  induction  (12)  of the 
microsomal  CO-binding  hemoprotein  cytochrome  P-448  or  P1-450  (13)  having 
catalytic properties intermediate between those produced by the phenobarbital 
and the 3-methylcholanthrene  (3-MC) or carcinogen types of inducers. Recently 
we have shown in cultured avian hepatocytes that the porphyrinogenic effects of 
several potent porphyria-inducing  compounds such as allylisopropylacetamide 
(AIA), 3,5-dicarbethoxy-l,4-dihydrocollidine (DDC), and the 5fl-steroid etiocho- 
lanolone can be blocked by pretreatment with cobalt chloride. 1 Moreover, when 
i Maines, M. D.,  P. Sinclair, and A. Kappas. 1976. Cobalt regulation of heme synthesis and 
degradation in avian liver cell culture. J. Biol. Chem.  In press. 
Abbreviations  used  in  this paper:  AIA, allylisopropylacetamide; ALA,  ~-aminolevulinate; 
ALAD, 8-aminolevulinic  acid dehydratase; ALAS, 8-aminolevulinate  synthetase; DDC, 3,5-dicar- 
bethoxy-l,4-dihydrocollidine;  PCB, polychlorinated biphenyls. 
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intact animals were pretreated with cobalt the metal was also able to block the 
induction of microsomal cytochrome P-450 by phenobarbital  (3) in the liver. 
In the present  study the ability  of cobalt to alter both the porphyrinogenic 
activity  of PCB  as  well  as  the  cytochrome  P-448-inducing  property  of these 
agents was investigated.  In addition, since the heme moiety of the microsomal 
hemoprotein cytochrome P-450 is known (8) to be metabolized by heme oxygen- 
ase,  the  possibility  of degradation  of PCB-induced  cytochrome  P-448 by  this 
enzyme was also investigated.  Finally, a new property of PCB was identified in 
its ability to depress hepatic activity ofS-aminolevulinate dehydratase (ALAD), 
the second enzyme in the heme biosynthetic pathway. 
Materials and Methods 
Materials.  Male Sprague-Dawley rats (170-185 g) were used throughout the study. All chemi- 
cals were purchased from Sigma Chemical Co., St. Louis, Mo. The PCB, Aroclor 1254, was a gift of 
the Monsanto Corp., St. Louis, Mo. 
Treatment of Animals and Tissue Preparation.  Rats were injected subcutaneously once with 
25  mg/kg  of PCB  in  corn  oil.  Cobalt(ous)  chloride  (250  ~mol/kg  in  saline)  was  also  injected 
subcutaneously  30  rain  before  the  injection of  PCB.  Control  animals  received  corresponding 
volumes of corn oil or saline as required.  In another series of experiments,  the animals were 
treated with PCB for 24 h, then were injected with the above dose of cobalt, and were killed 24 h 
later. The livers and kidneys were perfused in situ with 0.9% NaC1. The livers were homogenized 
in 0.05 M Tris-HC1 (0.1 M) buffer pH 7.4 containing 0.25 M sucrose. Aliquots of homogenate were 
removed for the assays of ALAS, 5-aminolevulinic acid dehydratase (ALAD), and total porphyrin 
content. The remainder was used for the preparation of the microsomal fractions as described 
previously (14). The kidneys were homogenized in potassium phosphate buffer, 0.1 M, pH 7.4, and 
microsomal fractions were prepared.  The liver supernatant fraction was used  as the  source of 
biliverdin reductase for the assay of heme oxygenase both in the liver and the kidney. 
Assays.  The activity of ALAS was measured as described by Marver et al.  (15) and that of 
ALAD by the method of Mauzerall and Granick (16) using dithiotriotol as the thiol activator. Total 
porphyrins were  measured by the fluorometric method of Sassa and Granick (17)  in a  Hitachi 
Perkin-Elmer  MPF-3  fluorescence  spectrophotometer  utilizing the  extraction  mixture  of  1  N 
perchloric acid:methanol (1:1,  vol/vol). 
Microsomal content of the CO-binding hemoproteins was measured by the method of Omura and 
Sato  (18).  Total  microsomal  heme  content was  measured  by  the  method  of Paul  et  al.  (19). 
Microsomal  ethylmorphine N-demethylase  activity was determined in the incubation medium 
described previously (14), measuring the amount of formaldehyde formed by the method of Nash 
(20). Microsomal heine oxygenase activity was assayed as described earlier (2) with the incubation 
being carried out aerobically in the dark. Protein content was determined by the method of Lowry 
et al. (21).  The Student's "t" test  was used as  the means of  statistical  evaluation of  the data, and the 
P  < 0.05 denoted statistical  significance. 
Results 
Fig.  1 shows the effect  of cobalt and the  combination of pretreatment  with 
cobalt and one injection of PCB on the enzymes that catalyze the first and second 
steps  in  the  heme  biosynthetic  pathway,  ALAS  and  ALAD,  as  well  as  the 
cellular porphyrin content. After 24 h, cobalt alone produced a 50% increase in 
ALAS activity and simultaneously inhibited ALAD activity to 50% of the control 
value.  There  was a  slight increase  in the cellular  porphyrin content.  PCB by 
itself produced an increase in ALAS which was of the same magnitude as that 
produced by cobalt alone; in addition there was also a slight increase in hepatic 
porphyrin  content.  PCB  treatment  resulted  in a  significant  inhibition  of the 
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FIG. i.  Cobalt effect  on  alterations  mediated  by PCB in  activities  of  the  enzymes ofheme 
biosynthetic  pathway and porphyrin  content in  the liver.  Rats  were pretreated  with  cobalt 
(250/~g/kg,  s.c.)  and 30  min later  treated  with  PCBs (25  mg/kg, s.c.).  24-h  later  the  animals 
were killed.  Assays were carried  out  as  described  in  the Materials and Methods section. 
synergistic inductive effect on ALAS activity and increased the total cell por- 
phyrin content as well. These values were both significantly greater than those 
produced by PCB  or cobalt alone.  ALAD activity was also depressed by the 
combination treatment, but this enzyme depression was not significantly differ- 
ent from that observed with cobalt treatment alone. 
Fig.  2  shows  the  effects of the  above  treatments on  microsomal enzymic 
parameters.  Consistent with our previous findings (1-6)  the microsomal con- 
tents of CO-binding hemoprotein P-450 and heme and ethylmorphine  N-demeth- 
ylation activity were decreased by cobalt treatment to the extent of 60-70%,  and 
there was a  10-14-fold increase in microsomal heme oxygenase activity. PCB 
alone produced a nearly 300% increase in microsomal CO-binding hemoprotein 
content with the hemoprotein being of the cytochrome P-448  type as  earlier 
described by Alvares et al.  (12). There also was a  major increase produced by 
PCB in microsomal heme content and a  similar increase in microsomal ethyl- 
morphine N-demethylase activity.  Microsomal heme oxygenase activity was 
somewhat increased in these  animals,  a  response  which may be  due  to the 
secondary effect of treatment, since it is known that starvation induces heme 
oxygenase activity. The refusal to consume food and the weight loss which was 
noted in these animals were most likely responsible for this slight increase in 
heme oxygenase activity. When cobalt was administered 30 min before the PCB 1512  CATABOLISM  OF  PCB-INDUCED  CYTOCHROME  P-448 
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FIG.  2.  Cobalt  effect  on  alterations  mediated  by  PCB  in  hepatic  microsomal  enzyme 
activities and heme and hemoprotein contents.  Hepatic microsomal fractions were prepared 
from rats treated as described in the legend in Fig.  1. The hepatic heme and hemoprotein 
content, and the oxidative activities of the microsomal fractions for heme and for ethylmor- 
phine, were measured as described in the Materials and Methods section. Microsomal heme 
oxygenase  activity  is  expressed  as  the  nanomoles  of bilirubin  produced  per  milligram 
protein  per  hour  and  that  of ethylmorphine  N-demethylase  activity  is  expressed  as the 
nanomoles  of formaldehyde  produced  per milligram  protein  per hour.  Cytochrome  P-450 
refers to the CO-binding hemoproteins,  P-450 and P~-450  (448). 
injection, the metal completely inhibited the induction of CO-binding hemopro- 
tein  and  of microsomal  heine  produced  by  PCB.  However,  microsomal  drug 
metabolizing activity,  as measured by the rate of ethylmorphine N-demethyla- 
tion, decreased to less than 50% of that in the control animals. The induction of 
hepatic  heine  oxygenase  activity  by cobalt was not altered  in the presence  of 
PCB (Fig. 2). Fig. 3 shows the effect of two (24-h intervals) sequential injections 
of PCB alone on hepatic ALAD activity.  PCB potently inhibited ALAD, reduc- 
ing this enzymic activity by 50% in 48 h. 
The  absorption spectrum of the CO-binding  hemoprotein from the livers  of 
animals treated with cobalt alone exhibited an absorption maximum at 450 nm, 
the same as in control  animals.  However,  the  absorption spectrum of micro- 
somes from the cobalt plus PCB-treated  animals exhibited an absorption maxi- 
mum at 448 nm as reported for PCB treatment alone (12). 
In another set of experiments the sequence of administration of the metal and 
of PCB was reversed.  Animals were pretreated with PCB for 24 h before cobalt 
administration,  in  order  to  increase  the  hepatic  content  of microsomal  cyto- MAHIN  D.  MAINES  1513 
40 
30 
E  20  i 





FIG. 3.  Inhibition  of hepatic 8-aminolevulinate  dehydratase by PCB. Rats were injected 
subcutaneously  once or two times with 25 mg/kg  of  Aroclor 1254. They were killed 24 h after 
the last injection,  and ALAD activity was measured in the whole  homogenate  as described 
in the Materials and Methods  section. 
chrome P-448 before heme oxygenase was induced. 24 h later the animals were 
killed. As Table I  shows,  cobalt administered after PCB treatment caused a 
substantial inhibition of the induction of ALAS elicited by PCB. This was in 
contrast to the synergistic inductive effect produced when cobalt was adminis- 
tered before PCB. The sequence of treatment had no effect on the inhibition of 
ALAD which was produced by both compounds (data not shown). PCB signifi- 
cantly induced hepatic microsomal hemoprotein (P-448 type) and heme contents, 
as noted earlier (12). Cobalt administration to PCB-pretreated animals mark- 
edly diminished microsomal hemoprotein content and substantially decreased 
total  microsomal heme  and  ethylmorphine N-demethylase activity.  The  se- 
quence of cobalt and PCB treatments did not alter the level of heme oxygenase 
activity, and this enzyme was as highly induced in these experiments as in the 
experiments shown in Fig. 2. Cobalt administration after PCB treatment shifted 
the  PCB-induced microsomal hemoprotein absorption  peak to a  wavelength 
somewhat longer than 448 nm in these animals. 
The effects of PCB alone, and of PCB on cobalt-induced changes in renal heme 
metabolic activity were also examined. The heme oxygenase system in kidney is 
highly responsive to induction by trace metals such as cobalt, tin, and related 
transitional elements (2,  6,  22); and concomitant with the alterations of this 
enzyme activity, there is a  decrease not only in renal heme and cytoplasmic 
hemoprotein contents and drug oxidative ability, but  also in the contents of 
mitochondrial  cytochromes  involved  in  oxidative  phosphorylation.  PCB,  as 
shown in Fig. 4, only increased renal heme content slightly as compared with 
liver (Fig. 2) and did not alter heme oxygenase activity at all. Cobalt substan- 
tially enhanced renal levels of heme oxygenase (Fig. 4), but the administration 
of PCB 30 min after cobalt administration almost entirely blocked the ability of 
the metal to induce heme oxygenase. PCB  simultaneously prevented the de- 
crease in renal heme content produced by the metal. 1514  CATABOLISM  OF  PCB-INDUCED  CYTOCHROME  P-448 
TABLE  I 
Effect of Cobalt on Various Cellular Heine-Related Parameters in PCB-Pretreated Rats 
Treatment  ALA  synthetase  Microsomal  Cytochrome  Ethylmorphine 
heme  P-450"  N-demethylase 
nmol/g per h  nmollmg  nmollmg  nmollmg per h 
Control  22,6  1.32  0.79  245,6 
PCB  58.5  2.12  1.81  275.2 
PCB  +  Co  38.1  0.86  0.39  101.1 
Co  47.1  0.95  0.35  60,4 
Rats were treated with PCBs (25 mg/kg, in corn oil,  i.p.).  24-h later  the animals were treated 
with cobalt  (60 mg/kg, s.c.),  they were then killed  24 h later.  The enzyme determinations  were 
made on appropriate cellular  fractions  as described in the Materials and Methods section. 
* CO-binding hemoprotein cytochrome P-450 and P~-450 (448). 
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FIO. 4.  Effect  of  PCB on renal microsomal heine oxygenase activity  and microsomal berne 
content and on  the influence  of  cobalt  on these parameters. The kidney of  rats  treated as in 
the legend of  Fig. 1 were utilized  for  the preparation of  the microsomal fractions  in which 
heine oxygenase activity  and heine content were measured. Heine oxygenase activity  is 
expressed as the nanomoles of  bilirubin  formed per milligram protein per hour. MAHIN  D.  MAINES  1515 
Discussion 
It has been demonstrated that cobalt (1-7),  as well as other transition ele- 
ments and heavy metals  (3,  4,  6,  22),  are potent regulators of cellular heme 
metabolism. Cobalt is a  highly active inducer of heme oxygenase, the micro- 
somal enzyme which degrades heme; it also regulates heme synthesis through 
its biphasic (inhibition followed by induction) actions on the activity of ALAS (2, 
5, 8), the rate-limiting enzyme in the heme biosynthetic pathway (23). Further- 
more, as shown here, cobalt can also significantly inhibit ALAD, the second 
enzyme in the heme biosynthetic sequence. One consequence of the cobalt effect 
on heme synthetic activity is the modifying influence which this metal exerts on 
hepatic cell responses to porphyrinogenic compounds  (5  and footnote 1).  Re- 
cently, we have shown that in whole animals (5), as well as in cultured avian 
hepatocytes,  l  pretreatment with cobalt was  an extremely effective means of 
blocking the potent porphyrinogenic action of compounds such as AIA, DDC, 
and 5fl-steroids. Also cobalt inhibits the induction of microsomal cytochrome P- 
450 produced by barbiturates  (3,  24). PCB  are known porphyrinogens which 
manifest their effects mainly through the induction of ALAS as  well  as the 
inhibition of uroporphyrinogen decarboxylase activities (11). However, the PCB 
possess  a  property that  is  quite  distinct from that  of other porphyrinogenic 
compounds-this is their ability to cause the induction of a novel type of hepatic 
microsomal hemoprotein, cytochrome P-448 (12). This cytochrome, which is also 
induced by polycyclic hydrocarbon carcinogens, is distinct from the native CO- 
binding hemoprotein P-450 not only in its spectral properties but in its catalytic 
activities as well (25). 
Previous studies have led us to the conclusion that the microsomal hemopro- 
teins are degraded in vivo by the action of cellular heme oxygenase system (3, 6, 
8).  However, these studies were limited to experiments with hepatocytes con- 
taining only cytochrome P-450.  The unique capacity of the PCB both to alter 
heme synthesis, as well as to induce cytochrome P-448, provided the opportunity 
to examine the ability of cobalt to modify the effects of PCB on heme synthesis 
and to study the possibility of degradation of microsomal hemoprotein of the P- 
448 type by the heme oxygenase system. 
The data presented in this report indicate that cytochrome P-448 is indeed 
degraded by the  microsomal  heme oxygenase system.  As  Fig.  2  shows  the 
cellular contents of heme and  PCB-induced cytochrome P-448  in  cobalt-pre- 
treated animals were greatly reduced in comparison to the animals treated with 
PCB alone. Since heme production, as judged by the activity of ALAS and the 
total porphyrin content, was not impaired in the cobalt-pretreated animals (Fig. 
1), the only plausible explanation for the depletion of cytochrome P-448 (Fig. 2) 
is  the  presence  of highly  elevated  heme  oxygenase  activity  in  the  cobalt- 
pretreated animals. This conclusion is further supported by the finding (Table I) 
that when cobalt was administered to animals in which the hemoprotein content 
had already been elevated by prior treatment with PCB, the microsomal hemo- 
protein  content  was  subsequently greatly reduced.  The  degradation  of pre- 
existing heme by the rapidly increasing heme oxygenase activity elicited by 
cobalt most likely was the explanation for the heme and hemoprotein depletions 
observed in this experiment. Thus it can be concluded that cytochrome P-448 
formed after cobalt treatment, as well as the P-448 formed before cobalt treat- 1516  CATABOLISM  OF  PCB-INDUCED  CYTOCHROME  P-448 
merit,  are both degraded by the microsomal heine oxygenase system, as is the 
case with cytochrome P-450 (6, 8). 
In earlier studies it was proposed that an initial step in the oxidative degrada- 
tion of cytochrome P-450 heme involves its endogenous conversion to the catalyt- 
ically inactive P-420 form, a species of the cytochrome in which the heine moiety 
is especially labile, as earlier studies of Maines and co-workers have shown (26, 
27). The lability of the P-420 heine moiety permits its transfer and binding to the 
heine oxygenase complex in microsomes, where its oxidative metabolism takes 
place. 
The results of the studies reported in Fig.  1 and Table I established that the 
heine  of cytochrome P-448  is  also metabolized by cobalt-induced  microsomal 
heine oxygenase. It is not clear whether the P-448 species of microsomal hemo- 
protein undergoes transition  to the P-420 form before serving as substrate for 
heme oxygenase as does P-450, but it is not unreasonable to believe that this is 
the case. Thus cytochrome P-420 may be considered to be the species through 
which all types of cytochrome P-450's are transformed before metabolic degrada- 
tion of their heroes to biliverdin and bilirubin. 
The time-dependent relationship between the actions of cobalt and PCB on the 
activity of ALAS (Fig.  1 vs. Table I) suggests that the porphyrinogen and the 
metal exer~ their effects on some common regulatory site for ALAS in hepato- 
cytes. Cobalt administration  before PCB synergized the inductive effect of PCB 
on ALAS activity. This synergism is probably composed of two separate compo- 
nents.  One  is  the  direct  induction  of ALAS  by  PCB  and  the  other  is  the 
secondary induction of ALAS produced by cobalt. As was noted cobalt regulates 
heine  synthesis in a  biphasic manner  (initial  inhibition  of ALAS followed by 
induction of the enzyme [2, 5, 8]). The initial inhibition of the enzyme is due to a 
direct action of the metal on ALAS synthesis; the secondary increase of ALAS 
results  from the  derepression  of enzyme synthesis which follows depletion  of 
cellular heine brought about by the increase in activity of heine oxygenase (5). 
ALAS formation is known to be regulated by cellular heine content (23); since 
the latter is determined by microsomal heine oxygenase activity, a  regulatory 
relationship between this enzyme and ALAS must exist. 
The finding that cobalt administered after PCB treatment did not synergize 
the inductive effect of PCB on ALAS reflects the direct inhibitory effect of cobalt 
on ALAS production.  In this instance it can be postulated that cobalt directly 
inhibited PCB-induced formation of ALAS; however, as the cellular content of 
heme was depleted the derepression of the enzyme, as was detailed above, would 
cause the induction of ALAS which in this experiment was of the same magni- 
tude as that observed with cobalt alone. 
The differing effects of PCB on the heme synthesizing  activity of liver and 
kidney are of interest with respect to control of the activity of this pathway in 
these  organs.  As  Fig.  3  shows,  PCB  in  the  kidney  did  not produce  a  major 
increase  in cellular  content of heme,  in contrast to the effect of PCB on this 
parameter in hepatocytes. This finding is consistent with other evidence which 
indicates that the mechanism by which heme synthesis is regulated in these two 
tissues is quite different. 3 
Finally,  it is apparent  from the inhibition  of ALAD activity reported here 
3 Maines, M. D., V. Janousek, J. M. Tomio, and A. Kappas. 1976. Manuscript in preparation. MAHIN  D.  MAINES  1517 
(Fig.  3) that  PCB alter enzymic activities in the heme pathway at more sites 
than previously recognized.  The finding that the activity of hepatic ALAD is 
inhibited by PCB and is a  time- and dose-dependent phenomenon is novel and 
would explain the excessive urinary excretion of ALA in PCB poisoning. 
Summary 
Polychlorinated biphenyls  (PCB) are potent inducers  of hepatic microsomal 
CO-binding  hemoprotein  P-448  (P~-450) and  of 8-aminolevulinate  synthetase 
(ALAS)  activity.  Inorganic  cobalt  was  able to  block PCB  induction  of cyto- 
chrome  P-448  and  to  modify  the  PCB  effect  on  ALAS  activity  in  8  time- 
dependent manner. PCB were also found to decrease the activity of  S-aminolevu- 
linic acid dehydratase (ALAD) in liver. 
Pretreatment of rats with cobalt (30 rain) produced the following changes in 
PCB actions on heme metabolism in liver: (a) augmentation of the porphyrino- 
genic effect of PCB,  as determined  by the total porphyrin content and ALAS 
activity; (b) augmentation of PCB inhibition of ALAD activity; and (c) blockade 
of induction of microsomal hemoprotein (cytochrome P-448). PCB did not inter- 
fere with cobalt induction of hepatic heme oxygenase activity. 
The sequence of administration  of the metal and the PCB was important  in 
relation  to  the  changes  produced  in  hepatic  ALAS  activity  and  microsomal 
hemoprotein and heme contents.  When cobalt was administered 24 h after PCB 
treatment, the magnitude of induction of ALAS by PCB was lowered, and there 
was a great reduction in microsom81 hemoprotein and heine contents. The renal 
response to PCB was different than that of the liver. In the kidney, PCB blocked 
the  induction  of heine  oxygenase and  depletion  of cellular  heine produced by 
cobalt.  Furthermore,  renal  microsomal  heme  content  was increased  by PCB 
treatment alone or in combination with cobalt. 
It is concluded that  (a) the heme moiety of microsomal cytochrome P-448 is 
metabolized by the  heine  oxygenase system,  and  it is suggested that  for this 
catabolism to take place, the hemoprotein must be first converted to the dena- 
tured form of the hemoprotein, cytochrome P-420;  (b) that the synthesis of heine 
in the kidney and the liver are regulated through different mechanisms; and (c) 
that ionic cobalt controls activity of ALAS by first inhibiting  synthesis of the 
enzyme  followed by the  indirect  induction  of the  enzyme  as  a  result  of the 
catabolism of heine, the physiological repressor of ALAS, by the metal-induced 
heine oxygenase. Thus microsomal heine oxygenase may be viewed as having an 
overall  regulatory  role  in  relation  to  mictochondrial  ALAS  by virtue  of its 
ability to catabolize endogenous heine. 
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